HCCI’s work on insulin pricing was cited in a Boston Globe article.
From the article:
“Following similar efforts in Colorado and Minnesota, the Senate bill also targets the costs of insulin, a commonly used drug that has become increasingly unaffordable for many patients.
On average, the price of all types of insulin roughly doubled between 2012 and 2016, according to the Washington-based Health Care Cost Institute.”
Senate leaders to offer antidote for high drug costs – The Boston Globe
Massachusetts Senate leaders will propose new legislation they say targets the high cost of prescription drugs, giving state officials the power to study and propose what they consider fair values for expensive medicines. This is their first major foray into a broader debate on Beacon Hill over health care.